{"id":"W2030638302","doi":"10.1200/jco.2014.56.5853","title":"Rituximab Extended Schedule or Re-Treatment Trial for Low–Tumor Burden Follicular Lymphoma: Eastern Cooperative Oncology Group Protocol E4402","year":2014,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":194,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute; American Society of Hematology","keywords":"Medicine; Rituximab; Follicular lymphoma; Internal medicine; Clinical endpoint; Oncology; Clinical trial; Surgery; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003335176,0.0004528047,0.004116193,0.0001709727,0.0001508464,0.00003734022,0.0002771767,0.0006981745,0.0002906779],"category_scores_gemma":[0.005226147,0.0002526791,0.001450606,0.000163401,0.0003134374,0.0001634391,0.00008607254,0.0003377192,0.0001033287],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001559148,"about_ca_system_score_gemma":0.005561534,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000437271,"about_ca_topic_score_gemma":0.0001507492,"domain_scores_codex":[0.9933183,0.001258508,0.00374791,0.0005768494,0.0005172429,0.0005811536],"domain_scores_gemma":[0.9897757,0.005293443,0.002754607,0.0004672229,0.0008880318,0.0008210508],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4336282,0.05904968,0.001638813,0.00009276584,0.002339444,0.003001167,0.0001734766,0.00001610575,0.00004983464,0.0005132857,0.004180598,0.4953166],"study_design_scores_gemma":[0.4022153,0.2069224,0.001558576,0.0001449976,0.0009629446,0.0005592345,0.0001473874,0.0005621138,0.0002644299,0.0001710879,0.3863359,0.0001556606],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8816853,0.0002018084,0.001173507,0.01511756,0.00350237,0.09401982,0.00002414969,0.00006492639,0.004210573],"genre_scores_gemma":[0.8807085,0.0001638276,0.03096908,0.005686955,0.01330647,0.06702586,0.00002632999,0.0001170202,0.001996019],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.495161,"threshold_uncertainty_score":0.9999925,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1323763385589371,"score_gpt":0.4866372121782168,"score_spread":0.3542608736192796,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}